Abstract:Objective:To explore the expression of ezrin in benign and invasive ductal carcinoma(IDC) samples of breast,and to analyse the correlation between ezrin expression and clinopathologic features such as age, maximum diameter of mass, TNM staging, differentiation, lymph node metastasis and expression of ER, PR, c-erbB-2, MMP-2, MMP-9, E-cadherin and so on in IDC. Methods: Ezrin and ER, PR, c-erbB-2, MMP-2, MMP-9, E-cadherin protein expression were assessed on a tissue microarray containing 101 IDC cases and 29 fibroadenoma cases, 8 adenosis cases. Furthermore, age, maximum diameter of mass, TNM staging, differentiation, lymph node metastasis and so on were analyzed. Results: The subcellular distribution of ezrin protein in benign and malignant breast lesions were significantly different. Ezrin protein localized at inner margin of the glandular tube in 91.89%(34/37) benign breast lesions, and no cytoplasm staining was observed; however, in 75.25%(76/101)of IDC cases, cytoplasm localizing of ezrin protein was observed, and inner margin staining of the glandular tube was observed in none case. In IDC cases, ezrin expression was positively related with maximum diameter (r=0.277, P=0.005), TNM stage(r=0.334, P=0.001), lymph-node metastases(r=0.323, P=0.001) , expression of MMP-9(r=0.246, P=0.013) in stromal cells. However, there was no significant relation between ezrin expression and age, histology grading and expression of ER, PR, c-erbB-2, MMP-2, MMP-9 in carcinoma cells as well as expression of MMP-2 in stroma cells. Conclusion: Ezrin protein localization in breast benign epithelial cells and carcinoma cells are remarkably different. It can be as a useful marker assisting the differential diagnosis of benign and malignant lesions in breast tumors. High expression level of ezrin in IDC suggests more aggressive and higher risk of lymph node metastasis.

The expression of Ezrin and CD44v6 in human breast cancer tissue and its significance

The Expression and Significance of Ezrin in the Genesis and Development of Human Breast Cancer

The Expression and Significance of Ezrin in Human Triple Negative Breast Cancer

Expression and clinical significance of ezrin in non--small-cell lung cancer.

Expression of Ezrin and CD44v6 and Their Clinical Significance in Gastric Carcinoma

Expression of Ezrin and its relationship with clinicopathological characteristics in breast cancer

[Relationship of Ezrin Protein Expression to the Carcinogenesis and Prognosis of Infitrating Breast Ductal Carcinoma].

Expression and CD147,MMP-9 and P-Erk in Invasive Ductal Carcinoma of Breast and Its Significance

[Expression and Clinical Significance of Adhesive Molecule CD44v6 in Breast Invasive Ductal Carcinoma].

Prognostic Significance of Ezrin Expression in Invasive Ductal Carcinoma of Breast

Expression of Ezrin in Metastatic Bone Tumor and Its Correlation with CD44V6

The expression of CD44v6, TGF -β1 and TGF -βR Ⅱ protein in breast neoplasm and its relationship with parameters of clinicopathological characteristics

Expression of CD44 and Its Clinical Significance in Breast Cancer Tissues

A study on the relationship between CD44v6 expression and biological characteristics in breast cancer

Expression and clinical significance of CD44 and Ezrin in the process of metastasis in human primary sporadic colorectal carcinoma

Clinical Significance of Cd44s, Cd44v3 and Cd44v6 in Breast Cancer

Expressions of Ezrin and IL-6 in cervical carcinoma and their dependability

Expression Patterns of Ezrin and AJAP1 and Clinical Significance in Breast Cancer

Expression and Its Clinical Significance of Ezrin Protein in Gastric Carcinoma

Expression of Ezrin in Pancreatic Carcinoma and Its Clinical Significance Using Tissue Microarrays

Significance and Expression of Ezrin in Non-small Cell Lung Cancer Tissue Micorarray